Zevia PBC (NYSE:ZVIA – Get Rating) had its price target upped by Wells Fargo & Company from $3.50 to $4.50 in a report published on Monday, Stock Target Advisor reports. The firm currently has an equal weight rating on the stock.

Separately, Morgan Stanley upped their price objective on Zevia PBC from $3.25 to $3.50 and gave the stock an equal weight rating in a research report on Monday, August 15th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average price target of $10.50.

Get Zevia PBC alerts:

Zevia PBC Stock Up 0.9 %

NYSE:ZVIA opened at $4.36 on Monday. The stock's fifty day moving average is $4.32 and its two-hundred day moving average is $3.65. Zevia PBC has a 52 week low of $1.86 and a 52 week high of $13.92. The stock has a market capitalization of $299.24 million, a price-to-earnings ratio of -2.27 and a beta of 0.09.

Insider Transactions at Zevia PBC

In related news, Director Padraic L. Spence sold 33,396 shares of the stock in a transaction on Monday, September 19th. The stock was sold at an average price of $4.47, for a total value of $149,280.12. Following the transaction, the director now owns 2,364,472 shares of the company's stock, valued at $10,569,189.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Padraic L. Spence sold 33,396 shares of the stock in a transaction on Monday, September 19th. The stock was sold at an average price of $4.47, for a total value of $149,280.12. Following the transaction, the director now owns 2,364,472 shares of the company's stock, valued at $10,569,189.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Padraic L. Spence sold 33,131 shares of the stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $4.85, for a total value of $160,685.35. Following the completion of the transaction, the director now directly owns 2,397,868 shares in the company, valued at approximately $11,629,659.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 98,971 shares of company stock valued at $410,217. 13.61% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Zevia PBC

Hedge funds have recently made changes to their positions in the company. Cubist Systematic Strategies LLC purchased a new position in shares of Zevia PBC during the second quarter worth about $42,000. Prelude Capital Management LLC purchased a new position in shares of Zevia PBC during the second quarter worth about $47,000. Diversified Trust Co purchased a new position in shares of Zevia PBC during the first quarter worth about $49,000. Qube Research & Technologies Ltd acquired a new stake in shares of Zevia PBC during the first quarter worth about $58,000. Finally, Penserra Capital Management LLC boosted its stake in shares of Zevia PBC by 70.0% during the first quarter. Penserra Capital Management LLC now owns 13,296 shares of the company's stock worth $60,000 after buying an additional 5,476 shares during the period. Hedge funds and other institutional investors own 40.67% of the company's stock.

About Zevia PBC

(Get Rating)

Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated and non-carbonated soft drinks in the United States and Canada. It offers soda, energy drinks, organic tea, mixers, kidz beverages, and sparkling water. The company offers its products through various retail channels, including grocery distributors, national retailers, warehouse club, and natural products retailers, as well as e-commerce channels.

See Also

• Get a free copy of the StockNews.com research report on Zevia PBC (ZVIA)
• Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
• 3 Stocks Growing Their Businesses for 2023
• China-Based EV Maker BYD Set For Big European, Japanese Expansion
• Is Illumina Still the Gamechanger in Genomics Sequencing?
• Here's What Makes Amazon a Sum-of-All-Parts Commerce Juggernaut

Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.